Results 111 to 120 of about 13,362 (238)
Internal Medicine Journal, Volume 55, Issue 10, Page 1626-1631, October 2025.Abstract Hyperhidrosis is an under‐reported and under‐treated condition that causes significant patient morbidity. Secondary causes require consideration, but the vast majority of cases are idiopathic. The condition is encountered by a range of clinicians, including neurologists, dermatologists and endocrinologists, and it pays to be familiar with the ...
Mitchell J. Lycett, Karl Ng
wiley +1 more source
Antipsychotics in the treatment of psychosis: risks and benefits [PDF]
, 2013 Antipsychotics are important in the treatment and recovery of people with psychosis but current evidence suggests that mental health nurses are not always conversant with the risks and benefits of these drugs.
Bressington, D., Mutsatsa, S.
core +1 more source
Journal of Diabetes Investigation, Volume 16, Issue 10, Page 1820-1828, October 2025.This study developed a clinical model using a gradient boosting decision tree (GBDT) to predict blood glucose reduction (ΔGlu) after continuous intravenous insulin therapy in hyperglycemic emergencies. A multicenter retrospective cohort analysis identified key predictive factors, including initial blood glucose, bicarbonate concentration, insulin flow ...
Yuichiro Iwamoto +18 more
wiley +1 more source
Türk Yoğun Bakim Derneği Dergisi, 2014 Neuroleptic malignant syndrome (NMS) is a rare but life-threatening clinical manifestation induced by neuroleptic medication. Although NMS is regarded as a psychiatric diagnosis, its treatment requires a systematic approach and thus intensive care follow-
Nazlı Gamze Bülbül +4 more
doaj +1 more source
Reduction or discontinuation of antipsychotics for challenging behaviour in adults with intellectual disability: a systematic review [PDF]
, 2017 The use of antipsychotics to manage challenging behaviour in adults with intellectual disability is widespread but controversial, and evidence is scarce.
Hassiotis, A, Sheehan, R
core +1 more source
Neuropathological Characterisation of McLeod Syndrome With a Proposed New Grading System
Neuropathology and Applied Neurobiology, Volume 51, Issue 5, October 2025.We report the neuropathological findings of the X‐linked McLeod neuroacanthocytosis syndrome (MLS), a very rare neurodegenerative disorder characterised by red blood cell acanthocytosis, chorea syndrome similar to Huntington’s disease, and additional neuromuscular and cardiological involvement.
Anna Maria Reuss +11 more
wiley +1 more source
Neuroleptic Malignant Syndrome Associated with Lithium Toxicity
Oman Medical Journal, 2016 Neuroleptic Malignant Syndrome (NMS) is an idiosyncratic and potentially life-threatening reaction to neuroleptic drugs. Lithium is a first-line mood stabilizer used in the treatment and prophylaxis of bipolar disorder.
Vaibhav Patil +3 more
doaj +1 more source
ADVERSE DRUG REACTIONS OF PSYCOPHARMACS [PDF]
, 2010 Background: The objective of analysis of ADRs caused by drugs that pertain to the ATC group N (nervous system), as reported to the Croatian Agency for Medicinal Products and Medical Devices for the period from March 2005 to December 2008, was to examine ...
Darko Krnić +7 more
core +1 more source
Neuroleptic malignant syndrome associated with metoclopramide. [PDF]
, 1985 Marilyn Beaton Robinson +4 more
openalex +1 more source
Journal of the Formosan Medical Association, 2006 Neuroleptic malignant syndrome (NMS) is a potentially lethal adverse reaction to neuroleptics, which is characterized by hyperthermia, extrapyramidal symptoms, altered consciousness and autonomic dysfunction.
Tsung-Chien Lu, Wen-Jone Chen
doaj +1 more source